352 related articles for article (PubMed ID: 36495325)
1. [
Mu X; Huang X; Jiang Z; Li M; Jia L; Lv Z; Fu W; Mao J
Eur J Nucl Med Mol Imaging; 2023 Mar; 50(4):1205-1215. PubMed ID: 36495325
[TBL] [Abstract][Full Text] [Related]
2. Comparison of
Sayiner ZA; Elboğa U; Sahin E; Ozturk S; Cayirli YB; Celen YZ; Akarsu E; Dogan I; Kilbas B; Eryilmaz K; Cakici D
Hell J Nucl Med; 2023; 26(1):41-46. PubMed ID: 37115220
[TBL] [Abstract][Full Text] [Related]
3.
Fu H; Wu J; Huang J; Sun L; Wu H; Guo W; Qiu S; Chen H
Radiology; 2022 Aug; 304(2):397-405. PubMed ID: 35536131
[TBL] [Abstract][Full Text] [Related]
4. PET Imaging of Fibroblast Activation Protein in Various Types of Cancer Using
Pang Y; Zhao L; Meng T; Xu W; Lin Q; Wu H; Zhang J; Chen X; Sun L; Chen H
J Nucl Med; 2023 Mar; 64(3):386-394. PubMed ID: 36215571
[TBL] [Abstract][Full Text] [Related]
5. The potential utility of [
Lan L; Liu H; Wang Y; Deng J; Peng D; Feng Y; Wang L; Chen Y; Qiu L
Eur J Nucl Med Mol Imaging; 2022 Feb; 49(3):963-979. PubMed ID: 34410435
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of [
Li C; Tian Y; Chen J; Jiang Y; Xue Z; Xing D; Wen B; He Y
Eur Radiol; 2023 Apr; 33(4):2779-2791. PubMed ID: 36394603
[TBL] [Abstract][Full Text] [Related]
7. [
Lin R; Lin Z; Chen Z; Zheng S; Zhang J; Zang J; Miao W
Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2960-2971. PubMed ID: 35462566
[TBL] [Abstract][Full Text] [Related]
8. Head-to-head comparison of [
Ballal S; Yadav MP; Roesch F; Satapathy S; Moon ES; Martin M; Wakade N; Sheokand P; Tripathi M; Chandekar KR; Agarwal S; Sahoo RK; Rastogi S; Bal C
Eur J Nucl Med Mol Imaging; 2023 Dec; 51(1):233-244. PubMed ID: 37642703
[TBL] [Abstract][Full Text] [Related]
9. Comparison of
Wang L; Tang G; Hu K; Liu X; Zhou W; Li H; Huang S; Han Y; Chen L; Zhong J; Wu H
Radiology; 2022 Apr; 303(1):191-199. PubMed ID: 34981976
[TBL] [Abstract][Full Text] [Related]
10. Value of [
Qiao K; Qin X; Fu S; Ren J; Jia J; Hu X; Tao Y; Yuan S; Wei Y
Eur Radiol; 2024 Mar; 34(3):1948-1959. PubMed ID: 37670186
[TBL] [Abstract][Full Text] [Related]
11. [
Wu C; Zhang X; Zeng Y; Wu R; Ding L; Xia Y; Chen Z; Zhang X; Wang X
Eur J Nucl Med Mol Imaging; 2022 Dec; 50(1):194-204. PubMed ID: 36040490
[TBL] [Abstract][Full Text] [Related]
12. Head-to-Head Comparison of [
Wegen S; van Heek L; Linde P; Claus K; Akuamoa-Boateng D; Baues C; Sharma SJ; Schomäcker K; Fischer T; Roth KS; Klußmann JP; Marnitz S; Drzezga A; Kobe C
Mol Imaging Biol; 2022 Dec; 24(6):986-994. PubMed ID: 35771317
[TBL] [Abstract][Full Text] [Related]
13. Head-to-head Intra-individual Comparison of [
Novruzov E; Dendl K; Ndlovu H; Choyke PL; Dabir M; Beu M; Novruzov F; Mehdi E; Guliyev F; Koerber SA; Lawal I; Niegisch G; Debus J; Haberkorn U; Sathekge M; Giesel FL
Mol Imaging Biol; 2022 Aug; 24(4):651-658. PubMed ID: 35349039
[TBL] [Abstract][Full Text] [Related]
14. Clinical Utility of F-18 Labeled Fibroblast Activation Protein Inhibitor (FAPI) for Primary Staging in Lung Adenocarcinoma: a Prospective Study.
Li Y; Lin X; Li Y; Lv J; Hou P; Liu S; Chen P; Wang M; Zhou C; Wang X
Mol Imaging Biol; 2022 Apr; 24(2):309-320. PubMed ID: 34816283
[TBL] [Abstract][Full Text] [Related]
15. Head-to-head comparison of
Zhang J; Jiang S; Li M; Xue H; Zhong X; Li S; Peng H; Liang J; Liu Z; Rao S; Chen H; Cao Z; Gong Y; Chen G; Zhang R; Zhang L
Cancer Imaging; 2023 Oct; 23(1):106. PubMed ID: 37899452
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the diagnostic efficacy of
Zhang Z; Jia G; Pan G; Cao K; Yang Q; Meng H; Yang J; Zhang L; Wang T; Cheng C; Zuo C
Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2877-2888. PubMed ID: 35243518
[TBL] [Abstract][Full Text] [Related]
17. Head-to-head intra-individual comparison of biodistribution and tumor uptake of
Giesel FL; Kratochwil C; Schlittenhardt J; Dendl K; Eiber M; Staudinger F; Kessler L; Fendler WP; Lindner T; Koerber SA; Cardinale J; Sennung D; Roehrich M; Debus J; Sathekge M; Haberkorn U; Calais J; Serfling S; Buck AL
Eur J Nucl Med Mol Imaging; 2021 Dec; 48(13):4377-4385. PubMed ID: 34137945
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic accuracy of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in differentiated thyroid cancer patients with elevated thyroglobulin and negative (131)I whole body scan: evaluation by thyroglobulin level.
Na SJ; Yoo IeR; O JH; Lin C; Lin Q; Kim SH; Chung SK
Ann Nucl Med; 2012 Jan; 26(1):26-34. PubMed ID: 21971605
[TBL] [Abstract][Full Text] [Related]
19.
Chen Y; Zheng S; Zhang J; Yao S; Miao W
Ann Nucl Med; 2022 Jul; 36(7):610-622. PubMed ID: 35551610
[TBL] [Abstract][Full Text] [Related]
20. Prognostic implication of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with recurrent papillary thyroid cancer.
Kang JH; Jung DW; Pak KJ; Kim IJ; Kim HJ; Cho JK; Shin SC; Wang SG; Lee BJ
Head Neck; 2018 Jan; 40(1):94-102. PubMed ID: 29130586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
